Hilton La Jolla Torrey Pines to Host Premier Lateral Flow Event with Enhanced Programming
LA JOLLA, Calif.— The 2025 Advanced Lateral Flow Conference (ALFC), presented by DCN Dx, is set to take place Oct. 14-15, 2025, in a stunning new location: the Hilton La Jolla Torrey Pines in La Jolla, California.
Known for its picturesque coastal views and world-class amenities, La Jolla offers attendees an upgraded experience while maintaining the convenience of southern California. The Hilton La Jolla Torrey Pines, located at 10950 North Torrey Pines Road, provides spacious accommodations, state-of-the-art facilities, and a serene environment that fosters both networking and innovation.
“We’re thrilled to host this year’s ALFC in La Jolla,” said Mitzi Rettinger, chair of the ALFC 2025 organizing committee. “The Hilton La Jolla Torrey Pines not only exceeds our needs for space and comfort but also offers attendees an incredible setting to connect and exchange ideas.”
Attendees will enjoy the same exceptional programming they’ve come to expect, including opportunities to engage with industry leaders, explore the latest technologies, and gain valuable insights into trends and commercialization strategies. The 2025 conference also promises exciting new features designed to enhance the experience and provide even greater value.
To make the event even more accessible, the venue is offering special negotiated rates for ALFC attendees. For more information and to book your stay, visit https://book.passkey.com/e/50944789. Prefer to call in your reservation? Call the Hilton La Jolla Torrey Pines at (877) 414-8020 and use Group Reservation Code ADVLAT.
To learn more and to register, visit ALFC2025.com.
About the Advanced Lateral Flow Conference
The Advanced Lateral Flow Conference (ALFC), presented by DCN Dx, is the leading global event for lateral flow diagnostic developers, manufacturers, and those driving their commercial success.
About DCN Dx
DCN Dx, based in Carlsbad, California, is a global leader in IVD CDMO and CRO services. Our multidisciplinary team specializes in creating tailored assay systems, consumables, and instruments for point-of-use applications, with a particular expertise in lateral flow assays.
Our personalized approach to IVD product development has supported more than 560 programs from over 260 clients. We can oversee every stage from concept to assay development and platform integration, through clinical trials to manufacturing or only handle the aspects you request. In addition to lateral flow assays, our clinical research expertise extends to a wide range of IVD devices, all with a focus on innovation, usability, and performance.
With a commitment to quality, customer satisfaction, and industry-leading expertise, DCN Dx is setting the benchmark for excellence in IVD services. To learn more about how we can support your diagnostic needs, visit dcndx.com.
